Skip to ContentSkip to Navigation
About us Latest news News News articles

Risk factors for late graft failure and mortality in renal transplantation

09 February 2011

PhD ceremony: Mr. A.P.J. Vries, 16.15 uur, Academiegebouw, Broerstraat 5, Groningen

Title: Risk factors for late graft failure and mortality in renal transplantation

Promotor(s): prof. R.O.B. Gans, prof. W.J. van Son

Faculty: Medical Sciences

 

Despite all improvements in transplant medicine, renal transplant patients have a high risk for cardiovascular mortality. A measure of heart failure, impaired renal allograft function, and antihypertensive medication, explained the excess risk for cardiovascular mortality to a greater extent than the presence of the metabolic syndrome.

A year after the transplantation, a majority of renal transplant recipients had developed the metabolic syndrome which is a risk factor for cardiovascular disease. The metabolic syndrome was defined as a complex of overweight or obesity, high blood pressure and an unfavourable profile of cholesterol variables. The metabolic syndrome is associated with impaired renal allograft function and increased insulin resistance.

Women suffered more often from post-transplant weight gain and metabolic syndrome than men. Overweight, in particular central obesity, and the immunosuppressant prednisolon were found as most important determinants of insulin resistance. Renal transplant recipients had a 6 to 7 times higher risk of premature mortality as compared to matched controls in the general population. A measure of heart failure, impaired renal allograft function, and antihypertensive medication, explained the cardiovascular risk factors more than the presence of the metabolic syndrome.

 

Last modified:13 March 2020 01.11 a.m.
View this page in: Nederlands

More news

  • 29 November 2023

    UMCG opent nieuwe faciliteit voor microbioomonderzoek 

    Vandaag opent het UMCG de Groningen Microbioom Hub: een nieuwe faciliteit met state-of-the-art technologie waarin alle UMCG-expertise op het gebied van microbioomonderzoek samenkomt. Dit zorgt voor unieke mogelijkheden in onderzoek en maakt nieuwe...

  • 28 November 2023

    Science: more exciting than showbiz

    Science often seems very complicated. Most people probably don't really know what researchers do, and what it takes to make a breakthrough. That is why it is important to keep the general public informed of what is happening in science, says Iris...

  • 13 November 2023

    UMCG beantwoordt vragen patiënten met hulp van AI

    Het UMCG zet kunstmatige intelligentie (artificial intelligence, afgekort AI) in om zorgverleners te helpen bij het beantwoorden van schriftelijke vragen van patiënten. Dit gebeurt in samenwerking met andere ziekenhuizen vanuit de EPIC Nederlandse...